[{"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-001", "question": "A 74-year-old man presents with heart failure with preserved ejection fraction (HFpEF) and bilateral carpal tunnel syndrome. Echocardiography reveals a granular 'sparkling' appearance of the myocardium and increased wall thickness. A technetium-99m pyrophosphate (PYP) scan shows Grade 3 cardiac uptake (uptake > rib uptake). Serum immunofixation reveals a small IgG lambda monoclonal protein, and serum free light chain ratio is 1.8. Which of the following is the most appropriate next step in management to confirm the diagnosis?", "options": ["Initiate tafamidis therapy", "Perform TTR genetic testing", "Endomyocardial biopsy", "Abdominal fat pad aspiration", "Initiate bortezomib, cyclophosphamide, and dexamethasone"], "answer": "C", "answer_index": 2, "explanation": "While Grade 2/3 PYP uptake is highly specific for ATTR cardiac amyloidosis, this specificity drops significantly in the presence of a monoclonal gammopathy (MGUS). AL amyloidosis can occasionally show uptake on PYP scans. Therefore, in a patient with a positive PYP scan AND a monoclonal protein, a tissue biopsy (endomyocardial is gold standard if non-cardiac biopsy is negative or to avoid sampling error) is mandatory to distinguish ATTR from AL amyloidosis before starting treatment.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient’s presentation (HFpEF, bilateral carpal tunnel, granular sparkling myocardium, increased wall thickness) and strongly positive Tc-99m PYP scan (Grade 3 uptake) point strongly to transthyretin amyloidosis (ATTR-CM), either wild-type or hereditary.  \nThe presence of a small monoclonal protein does not rule out ATTR-CM, as monoclonal gammopathy can be incidental in this age group.  \nThe most appropriate next step to confirm the diagnosis, given the positive PYP scan, is **TTR genetic testing** to distinguish between wild-type and hereditary ATTR amyloidosis, which guides therapy and family screening.  \nEndomyocardial biopsy (C) is definitive but invasive and not necessary if non-biopsy diagnostic criteria for ATTR-CM are met (which they appear to be).  \nAbdominal fat pad aspiration (D) is less sensitive for ATTR-CM than for AL amyloidosis.  \nStarting tafamidis (A) or chemotherapy (E) without definitive typing would be premature.  \n\nThe answer is B"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-002", "question": "A 24-year-old male presents with recurrent fevers, livedo racemosa, and acute left hemiparesis. MRI shows a lacunar infarct in the internal capsule. Angiography reveals a 'beads-on-a-string' appearance in the mesenteric and renal arteries. Laboratory evaluation shows low serum IgM and IgG levels. Genetic testing confirms a biallelic loss-of-function mutation in ADA2. Which of the following is the most appropriate maintenance therapy?", "options": ["Cyclophosphamide", "Rituximab", "Etanercept", "Prednisone monotherapy", "Plasma exchange"], "answer": "C", "answer_index": 2, "explanation": "The patient has Deficiency of Adenosine Deaminase 2 (DADA2), which mimics Polyarteritis Nodosa (PAN) but is distinct due to its association with early-onset strokes and hypogammaglobulinemia. Unlike classic PAN, which is treated with cyclophosphamide, DADA2 is driven by TNF-alpha dysregulation. TNF inhibitors (like etanercept) are the treatment of choice and are highly effective in preventing recurrent strokes, whereas cyclophosphamide is often ineffective.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has deficiency of adenosine deaminase 2 (DADA2), confirmed by biallelic loss-of-function mutations in *ADA2*.  \nClinical features include recurrent fevers, livedo racemosa, early-onset lacunar strokes, and vasculopathy with a “beads-on-a-string” angiographic pattern.  \nLow serum IgM and IgG can occur due to B-cell lymphopenia in some patients.  \n\nFor DADA2, the first-line maintenance therapy to prevent vascular and inflammatory complications is **anti-TNF agents** (such as etanercept, infliximab, or adalimumab), which reduce inflammation and stroke risk. Cyclophosphamide, rituximab, prednisone monotherapy, and plasma exchange are not appropriate as long-term maintenance for DADA2.  \n\nThe answer is C"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-003", "question": "A 64-year-old male presents with a 1-year history of progressive gait instability, dysarthria, and dysphagia. His wife reports he has severe insomnia, stridor during sleep, and acts out his dreams. Polysomnography confirms obstructive sleep apnea and complex behaviors during both REM and NREM sleep. MRI brain is unremarkable. Which of the following antibodies is most likely to be positive?", "options": ["Anti-Hu", "Anti-Ma2", "Anti-LGI1", "Anti-IgLON5", "Anti-DPPX"], "answer": "D", "answer_index": 3, "explanation": "Anti-IgLON5 disease is a distinct tauopathy characterized by a unique sleep disorder (parasomnias in both REM and NREM sleep, stridor, OSA) combined with bulbar dysfunction and gait instability. While Anti-Ma2 is associated with brainstem/diencephalic involvement and sleepiness, the specific combination of stridor, NREM parasomnias, and bulbar palsy is pathognomonic for Anti-IgLON5.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "The patient’s symptoms — progressive gait instability, dysarthria, dysphagia, severe insomnia, stridor, REM and NREM sleep parasomnias, and obstructive sleep apnea — with a normal MRI are highly characteristic of **anti-IgLON5 disease**, a tauopathy with prominent sleep and bulbar dysfunction.  \n\nAnti-Hu is associated with paraneoplastic encephalomyelitis, often with sensory neuropathy.  \nAnti-Ma2 is linked to limbic and brainstem encephalitis, often with hypothalamic and brainstem signs.  \nAnti-LGI1 causes limbic encephalitis with faciobrachial dystonic seizures.  \nAnti-DPPX presents with agitation, myoclonus, tremor, and gastrointestinal symptoms.  \n\nThe combination of sleep apnea, stridor, parasomnias, and bulbar symptoms points most specifically to anti-IgLON5.  \n\nThe answer is D"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-004", "question": "A 68-year-old male presents with fever of unknown origin, 15 kg weight loss, and fatigue 4 years after undergoing aortic valve replacement. Labs reveal pancytopenia and elevated liver enzymes. TTE and TEE show no vegetations. PET-CT demonstrates hypermetabolic activity in the spleen and bone marrow. Bone marrow biopsy reveals non-caseating granulomas. Standard blood cultures are negative. Which of the following is the most likely etiology?", "options": ["Sarcoidosis", "Culture-negative endocarditis (HACEK group)", "Mycobacterium chimaera", "Tropheryma whipplei", "Late-onset prosthetic valve thrombosis"], "answer": "C", "answer_index": 2, "explanation": "This is the classic presentation of disseminated *Mycobacterium chimaera* infection associated with contaminated heater-cooler units used during cardiopulmonary bypass. The incubation period can be several years. It presents with systemic symptoms, cytopenias, and granulomatous inflammation (often misdiagnosed as sarcoidosis). Diagnosis requires specific mycobacterial blood cultures or tissue PCR.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient has a history of prosthetic aortic valve replacement, with symptoms and findings suggesting an indolent infection: fever, weight loss, pancytopenia, elevated liver enzymes, splenic and bone marrow hypermetabolism on PET, non-caseating granulomas in bone marrow, and negative standard blood cultures.  \n\n**Key clues:**  \n- Prosthetic valve + negative TEE for vegetations + negative standard blood cultures + granulomatous inflammation.  \n- *Mycobacterium chimaera* is a known cause of disseminated infection from heater–cooler unit contamination during cardiac surgery, typically presenting months to years later with nonspecific symptoms, culture-negative endocarditis-like picture, granulomas, and often negative TEE for vegetations.  \n\nSarcoidosis (A) could cause granulomas but wouldn’t typically be tied so closely to a prosthetic valve surgery timeline.  \nHACEK (B) might cause culture-negative endocarditis but usually shows vegetations and doesn’t typically cause granulomas.  \nTropheryma whipplei (D) causes Whipple’s disease with different histology (PAS-positive macrophages).  \nProsthetic valve thrombosis (E) wouldn’t cause fever, weight loss, granulomas, or hypermetabolic spleen/bone marrow.  \n\nThe best match is **Mycobacterium chimaera**.  \n\nThe answer is C"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-005", "question": "A 31-year-old female presents with amenorrhea 4 months after a full-term delivery. Ultrasound reveals a 4 cm echogenic mass in the myometrium. Serum beta-hCG is 120 IU/L. Immunohistochemistry of a biopsy specimen shows diffuse positivity for human placental lactogen (hPL) and Ki-67 index of 15%. Staging workup is negative for metastasis. What is the treatment of choice?", "options": ["Methotrexate and Folinic Acid", "Actinomycin D", "EMA-CO regimen", "Hysterectomy", "Pembrolizumab"], "answer": "D", "answer_index": 3, "explanation": "The diagnosis is Placental Site Trophoblastic Tumor (PSTT), distinguished from choriocarcinoma by low beta-hCG, strong hPL positivity, and origin from intermediate trophoblasts. Unlike choriocarcinoma, PSTT is relatively resistant to chemotherapy. For localized (Stage I) disease, hysterectomy is the primary and definitive treatment. Chemotherapy is reserved for metastatic or high-risk disease.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "The patient has a placental site trophoblastic tumor (PSTT), based on:  \n- Presentation with amenorrhea after a full-term delivery.  \n- Ultrasound showing an echogenic myometrial mass.  \n- Low beta-hCG (PSTT often produces low levels).  \n- Immunohistochemistry: diffuse hPL positivity (characteristic of PSTT) and Ki-67 index of 15% (consistent with PSTT, not choriocarcinoma, which usually has much higher Ki-67).  \n- Staging negative for metastasis.  \n\nPSTT is resistant to standard chemotherapy used for other gestational trophoblastic neoplasias (like methotrexate or EMA-CO). The primary treatment for localized PSTT is hysterectomy, as it is a surgical disease.  \n\nThe answer is D"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-006", "question": "A 40-year-old male with a known diagnosis of Brugada syndrome presents to the ER in electrical storm, having received 4 appropriate ICD shocks for ventricular fibrillation in the past hour. He is currently conscious but anxious. Vital signs are BP 110/70, HR 90. Which pharmacologic agent is most appropriate to suppress the arrhythmia?", "options": ["Intravenous Amiodarone", "Intravenous Lidocaine", "Intravenous Isoproterenol", "Intravenous Procainamide", "Intravenous Metoprolol"], "answer": "C", "answer_index": 2, "explanation": "In Brugada syndrome electrical storm, the goal is to decrease the ST-segment elevation and dispersion. Isoproterenol (a beta-agonist) increases heart rate and calcium current, normalizing the ST segment and suppressing VF. Quinidine is the oral alternative. Amiodarone, beta-blockers, and sodium channel blockers (Procainamide, Lidocaine) are contraindicated or ineffective as they can unmask or exacerbate the Brugada pattern.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "In Brugada syndrome, electrical storm (recurrent VF) is often triggered by increased vagal tone or other factors that accentuate the type 1 Brugada ECG pattern.  \nIsoproterenol, a β-adrenergic agonist, increases heart rate and reduces the inhomogeneity of repolarization in the right ventricular outflow tract, suppressing VF episodes in this setting.  \nOther antiarrhythmics like amiodarone, procainamide, or flecainide (not listed) can worsen the Brugada pattern and are generally avoided. Lidocaine has limited evidence, and beta-blockers may be detrimental by allowing unopposed vagal tone.  \n\nThe answer is C"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-007", "question": "A 32-year-old female presents with subacute confusion, bilateral hearing loss, and visual field deficits. MRI brain shows multiple T2 hyperintense lesions in the corpus callosum ('snowballs') and periventricular white matter. Fluorescein angiography reveals multiple branch retinal artery occlusions (BRAO). CSF shows mild pleocytosis and elevated protein but no oligoclonal bands. What is the most likely diagnosis?", "options": ["Multiple Sclerosis", "CADASIL", "Susac Syndrome", "Primary CNS Angiitis", "Mitochondrial Encephalomyopathy (MELAS)"], "answer": "C", "answer_index": 2, "explanation": "Susac Syndrome is a rare autoimmune endotheliopathy characterized by the clinical triad of encephalopathy, branch retinal artery occlusions (BRAO), and sensorineural hearing loss. The MRI finding of 'snowball' lesions in the corpus callosum is highly characteristic. It is often misdiagnosed as MS, but the presence of BRAO and callosal lesions (rather than callososeptal interface lesions) distinguishes it.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The presentation includes a classic triad of **encephalopathy (subacute confusion), hearing loss, and branch retinal artery occlusions (BRAO)**.  \nMRI findings of **corpus callosum lesions (“snowballs”)** are highly characteristic of **Susac syndrome**, which is a microangiopathy affecting the brain, retina, and inner ear.  \nCSF lacking oligoclonal bands and the fluorescein angiography findings further support this over MS, CADASIL, CNS angiitis, or MELAS.  \n\nThe answer is C"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-008", "question": "A 29-year-old male who has sex with men presents with severe proctitis, tenesmus, and rectal bleeding. Rectal swab NAAT is positive for *Chlamydia trachomatis*. He was treated with Doxycycline 100 mg BID for 7 days with no improvement. His partner recently returned from Europe. Which of the following is the most appropriate management?", "options": ["Repeat Doxycycline 100 mg BID for 7 days", "Azithromycin 1 g single dose", "Ceftriaxone 500 mg IM single dose", "Extend Doxycycline 100 mg BID to complete a 21-day course", "Moxifloxacin 400 mg daily for 14 days"], "answer": "D", "answer_index": 3, "explanation": "Severe proctitis in MSM with a positive Chlamydia test should raise suspicion for Lymphogranuloma Venereum (LGV), caused by L1, L2, or L3 serovars. LGV requires a prolonged course of doxycycline (21 days) compared to non-LGV chlamydia (7 days). Standard treatment failure and severe symptoms (bleeding/tenesmus) strongly support a diagnosis of LGV.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "The patient has persistent severe proctitis after a standard 7-day doxycycline course for rectal *Chlamydia trachomatis*.  \nGiven the partner’s recent travel to Europe, consider possible lymphogranuloma venereum (LGV) serovars (L1–L3), which require longer antibiotic therapy.  \nFor LGV proctitis, guidelines recommend doxycycline 100 mg BID for 21 days.  \nOther options (repeat short-course doxycycline, azithromycin 1 g single dose, ceftriaxone, or moxifloxacin 14 days) are not first-line for LGV proctitis after doxycycline failure in this context.  \n\nThe answer is (D)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-009", "question": "A 70-year-old man is evaluated for macrocytic anemia (MCV 105), thrombocytopenia, and recurrent inflammation of the ear and nose cartilage. He also has pulmonary infiltrates. Bone marrow biopsy demonstrates hypercellularity with vacuolization of myeloid and erythroid precursor cells. Genetic sequencing identifies a somatic mutation in *UBA1*. What is the diagnosis?", "options": ["Relapsing Polychondritis", "Myelodysplastic Syndrome (MDS)", "VEXAS Syndrome", "Sweet Syndrome", "Granulomatosis with Polyangiitis"], "answer": "C", "answer_index": 2, "explanation": "VEXAS (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic) syndrome is a recently described disorder caused by somatic mutations in *UBA1*. It connects inflammatory features (polychondritis, vasculitis, infiltrates) with hematologic features (macrocytic anemia, vacuoles in marrow precursors). While it mimics relapsing polychondritis, the presence of marrow vacuoles and the *UBA1* mutation defines VEXAS.", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "The patient is a 70-year-old man with macrocytic anemia, thrombocytopenia, recurrent inflammation of ear and nose cartilage (suggesting chondritis), pulmonary infiltrates, and a bone marrow biopsy showing hypercellularity with vacuolization of myeloid and erythroid precursors.  \nThe key clue is the **somatic mutation in *UBA1***.  \nThis mutation is diagnostic of **VEXAS syndrome** (Vacuoles, E1 enzyme, X-linked, Autoinflammatory, Somatic), which presents with systemic autoinflammatory symptoms (relapsing polychondritis-like features), hematologic abnormalities (macrocytic anemia, thrombocytopenia), and characteristic vacuoles in myeloid/erythroid precursors in the bone marrow.  \n\nThe answer is C.  \n\nThe answer is (C)"}, {"quiz_id": "20251129T125426901Z_gemini-3-pro-preview_seed124", "question_id": "20251129T125426901Z_gemini-3-pro-preview_seed124-010", "question": "A 35-year-old female undergoes a cone biopsy for CIN 3. Pathology reveals invasive squamous cell carcinoma with 2 mm depth of invasion and 5 mm horizontal spread. Lymphovascular space invasion (LVSI) is extensively present. Margins are negative. Imaging shows no lymphadenopathy. She desires future fertility. According to NCCN guidelines, what is the recommended management?", "options": ["Simple trachelectomy", "Radical trachelectomy with pelvic lymph node assessment", "Conization with negative margins is sufficient", "Simple hysterectomy", "Pelvic radiation therapy"], "answer": "B", "answer_index": 1, "explanation": "The patient has Stage IA1 cervical cancer (invasion <= 3mm). However, the presence of Lymphovascular Space Invasion (LVSI) significantly increases the risk of lymph node metastasis and recurrence. Therefore, simple excision (cone) or simple trachelectomy/hysterectomy is insufficient. The recommended management for fertility preservation in IA1 with LVSI is radical trachelectomy with pelvic lymph node assessment (sentinel node or dissection).", "generator_model": "gemini-3-pro-preview", "seed": 124, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "The patient has invasive squamous cell carcinoma with 2 mm depth of invasion and 5 mm horizontal spread, which meets the definition of stage IA1 cervical cancer.  \nHowever, the presence of **extensive lymphovascular space invasion (LVSI)** changes management per NCCN guidelines.  \n\nFor stage IA1 with LVSI, the risk of lymph node metastasis is increased, and NCCN recommends **radical trachelectomy with pelvic lymph node assessment** if fertility preservation is desired.  \nSimple trachelectomy or conization alone would be inadequate due to the extensive LVSI.  \n\n**The answer is B**"}]